The US Food and Drug Administration (FDA) on Friday authorized the emergency use of Moderna and Pfizer-BioNTech’s COVID-19 vaccines for children as young as 6 months of age, asserting that the ...
A top adviser has resigned from the Food and Drug Administration's (FDA) vaccine advisory committee amid concerns about her ...
The US Food and Drug Administration (FDA) on Wednesday authorized bivalent COVID-19 vaccines targeting the Omicron BA.4/5 subvariants developed by Pfizer-BioNTech and Moderna, asserting that the ...
The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...
GSK has secured an FDA expansion for its respiratory syncytial virus (RSV) vaccine, Arexvy, for adults ages 18 to 49 who are at increased risk of lower respiratory tract disease caused by the virus.
MedPage Today on MSN
FDA's Vaccine Panel to Weigh XFG Variant for New COVID Shots
But advisors will take a hard look at "Cicada" variant as well ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
The much-needed shots are expected to be given starting Monday, just three days after the Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results